Sandy Draper
Stock Analyst at Guggenheim
(3.66)
# 640
Out of 4,817 analysts
119
Total ratings
57.73%
Success rate
18.66%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $282.28 | +53.04% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $143.61 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $106.89 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $8.62 | +294.43% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.46 | +124.22% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $52.40 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $2.71 | -26.20% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $136.79 | +92.27% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $4.00 | +650.00% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $83.45 | +12.64% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $6.92 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $22.83 | +123.39% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $144.70 | -10.85% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $31.11 | +76.82% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $44.15 | +280.52% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $25.35 | -52.66% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $19.63 | +93.58% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $3.41 | +1,368.43% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $9.74 | +567.35% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $3.68 | +878.26% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $215.68 | -22.57% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.35 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $12.08 | +421.52% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $282.28
Upside: +53.04%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $143.61
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $106.89
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $8.62
Upside: +294.43%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.46
Upside: +124.22%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $52.40
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $2.71
Upside: -26.20%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $136.79
Upside: +92.27%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $4.00
Upside: +650.00%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $83.45
Upside: +12.64%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $6.92
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $22.83
Upside: +123.39%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $144.70
Upside: -10.85%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $31.11
Upside: +76.82%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $44.15
Upside: +280.52%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $25.35
Upside: -52.66%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $19.63
Upside: +93.58%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $3.41
Upside: +1,368.43%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $9.74
Upside: +567.35%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $3.68
Upside: +878.26%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $215.68
Upside: -22.57%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.35
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $12.08
Upside: +421.52%